NOMIC BIO
Nomic develops a proteomic technology platform designed to understand, detect, and treat diseases with DNA nanotechnology. NPlex's platform and research provides cost-effective measurement of protein data with sample, fits seamlessly within industry cytometers for high-throughput analysis, and development of custom protein panels. It allows nanotechnology developers and businesses to bring improvement in existing instrument, workflow, and bring automation in the system.
NOMIC BIO
Industry:
Biotechnology Health Diagnostics Market Research Nanotechnology
Founded:
2017-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.nomic.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
18.03 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business Amazon Route 53 Amazon CloudFront
Current Advisors List
Current Employees Featured
Founder
Investors List
SR One
SR One investment in Series A - Nomic Bio
Casdin Capital
Casdin Capital investment in Series A - Nomic Bio
Lux Capital
Lux Capital investment in Series A - Nomic Bio
CQDM
CQDM investment in Grant - Nomic Bio
TechU Ventures
TechU Ventures investment in Seed Round - Nomic Bio
Front Row Ventures
Front Row Ventures investment in Venture Round - Nomic Bio
Uncommon Denominator
Uncommon Denominator investment in Venture Round - Nomic Bio
Y Combinator
Y Combinator investment in Venture Round - Nomic Bio
Y Combinator
Y Combinator investment in Pre Seed Round - Nomic Bio
First Star Ventures
First Star Ventures investment in Pre Seed Round - Nomic Bio
Official Site Inspections
http://www.nomic.bio
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Nomic Bio"
Nomic - Crunchbase Company Profile & Funding
Contact Email [email protected] Nomic is a bioengineering company working to make the human proteome as broadly and easily accessible as the human …See details»
Nomic Bio - LinkedIn
The Nomic Bio R&D team is growing in Boston! As we grow the team across our Montreal and Boston sites, I am looking for a talented and dynamic (Sr.) Scientist to join our immunoassay platform ...See details»
Nomic 2025 Company Profile: Valuation, Funding
Nomic General Information Description. Developer of a throughput proteomic platform designed to make the human proteome easily accessible as the …See details»
Nomic Bio Profile | The Scientist
Nomic Bio. Content by Nomic Bio. Mapping Cytokine Interactions via a 10,000-Well Perturbation Screen. Nomic Bio | | 1 min read. High-throughput protein profiling technology enables …See details»
Rebranded Nomic Bio raises $17 million to fuel …
Dec 8, 2021 Nomic Bio has secured a new name and $17 million USD in Series A financing to support the growth of its protein-measuring platform.. Nomic hopes to “revolutionize” how drugs are developed and diseases are diagnosed and …See details»
Nomic Bio Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nomic Bio Inc of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
Nomic - Company Profile - Tracxn
Feb 25, 2025 Nomic Bio Appoints Byron Hewett to its Board of DirectorsBusiness Wire • Jun 28, 2023 • Nomic, Somalogic Nomic Closes $17 Million Series A to Develop and Commercialize …See details»
Nomic® Secures $42M in Oversubscribed Series B to Expand …
Montreal – September 17th, 2024 – Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh …See details»
Meet Nomic Bio: Our Mission and Team | Nomic Bio
Advancing Biotechnology: At Nomic Bio, our mission is to push the boundaries of biotechnology through cutting-edge research, innovation, and collaboration. Improving Lives : We are …See details»
Nomic - The Protein Profiling Company
Learn how Nomic's nELISA™ enables high-fidelity multiplexing, à-la-carte protein selection, and unmatched cost-efficiency. All using a white-glove service with end-to-end support and a 1 …See details»
Nomic Bio - Osler, Hoskin & Harcourt LLP
On September 17, 2024, Nomic Bio announced its closing of a $42-million Series B financing round. This round was led by a U.S.-based life-sciences-focused investor and also saw …See details»
Nomic Company Profile | Management and Employees List
Nomic Bio. Nomic. Nplex Biosciences. Primary Industries. Healthcare Software Software. Contact Information. Headquarters. 5333 Casgrain Ave Ste 401, Montreal, Quebec, H2T 1X3, Canada. …See details»
Nomic collects $17M to advance its automated, high-throughput …
Dec 8, 2021 A Canadian startup aims to give the decades-old, hand-performed ELISA test a 21st century upgrade by transforming the humble immunoassay into a high-throughput protein …See details»
Nomic Company Information - Funding, Investors, and More
Nomic Bio Series A round, December 2021: $17m; 2024. Nomic September 2024 Series B Funding Round $42m. 2021. Nomic Bio Series A round, December 2021 $17m. Industries. …See details»
Nomic - Crunchbase Company Profile & Funding
Organization. Nomic . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Similar Companies 3. Recent News & Activity. News • Dec 9, 2021. …See details»
Nomic Bio’s Series B — Making proteomics accessible
Sep 17, 2024 Nomic Bio. At Nomic, we are making protein profiling broadly accessible. At the heart of our platform is the nELISA, a proprietary technology that enables massive multiplexing …See details»
Nomic Bio – Funding, Valuation, Investors, News
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the …See details»
Nomic Company Profile - Office Locations, Competitors, Revenue …
Nomic (formerly known as nplex Biosciences) is a bioengineering company developing a proteomics platform to understand, detect, and treat diseases. It uses DNA nanotechnology, …See details»
Nomic® Secures $42M in Oversubscribed Series B to Expand …
Sep 17, 2024 MONTREAL--(BUSINESS WIRE)--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding …See details»
Nomic Bio Company Profile: Funding, Investors & Partnerships
Oct 15, 2022 Nomic Bio. Submit feedback Claim this profile. At Nomic, we are making protein profiling broadly accessible. At the heart of our platform is the nELISA, a proprietary …See details»